Stem cell-derived dopamine neurons for brain repair in Parkinsons disease

Regenerative Medicine

Volumn 5, Issue 2, 2010, Pages 267-278

  Fricker Gates, Rosemary A ^a   Gates, Monte A ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Animal models; Bone marrow stem cells; Differentiation; Dopamine neuron; Embryonic stem cells; Induced pluripotent stem cells; Neural stem cells; Parkinson's disease; Review; Transplant

Indexed keywords

DOPAMINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; NUCLEAR RECEPTOR RELATED FACTOR 1; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LMX1B; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ADULT STEM CELL; CELL DIFFERENTIATION; CELL TYPE; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; HUMAN; MEDICAL RESEARCH; MESENCEPHALON; MOTOR PERFORMANCE; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

ANIMALS; BRAIN; DOPAMINE; HUMANS; NEURONS; PARKINSON DISEASE; STEM CELLS; WOUND HEALING;

EID: 77949382479     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.3     Document Type: Review

References (123)

1. Lindvall O, Björklund A: Cell therapy in Parkinson's disease. NeuroRx 1, 382-393 (2004).
2. Honegger P, Lenoir D, Favrod P: Growth and differentiation of aggregating fetal brain cells in a serum-free defned medium. Nature 282, 305-308 (1979).
3. Eccleston PA, Gunton DJ, Silberberg DH: Requirements for brain cell attachment, survival and growth in serum-free medium: effects of extracellular matrix, epidermal growth factor and fbroblast growth factor. Dev. Neurosci. 7, 308-322 (1985).
4. Pulliam L, Berens ME, Rosenblum ML: A normal human brain cell aggregate model for neurobiological studies. J. Neurosci. Res. 21, 521-530 (1988).
5. Reynolds BA, Tetzlaff W, Weiss S: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12, 4565-4574 (1992).
6. Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL: Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Brain Res. Dev. Brain Res. 158, 120-122 (2005).
7. Ling ZD, Potter ED, Lipton J W, Carvey PM: Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149, 411-423 (1998).
8. Yu Y, Gu S, Huang H, Wen T: Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. J. Neurol. Sci. 255, 81-86 (2007).
9. Pei Y, He X, Xie Z: Dopaminergic neuron differentiation of ventral mesencephalic progenitors regulated by developmental signals in vitro. NeuroReport 14, 1567-1570 (2003).
10. Studer L, Csete M, Lee SH et al.: Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20, 7377-7383 (2000).
11. Rodriguez-Pallares J, Caruncho HJ, Guerra MJ, Labandeira-Garcia JL: Dipyridamole-induced increase in production of rat dopaminergic neurons from mesencephalic precursors. Neurosci. Lett. 320, 65-68 (2002).
12. Volpicelli F, Consales C, Caiazzo M et al.: Enhancement of dopaminergic differentiation in proliferating midbrain neuroblasts by sonic hedgehog and ascorbic acid. Neural Plast. 11, 45-57 (2004).
13. Peaire AE, Takeshima T, Johnston JM et al.: Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease. J. Neurosci. Methods 124, 61-74 (2003).
14. Jin G, Tan X, Tian M et al.: The controlled differentiation of human neural stem cells into TH-immunoreactive (ir) neurons in vitro. Neurosci. Lett. 386, 105-110 (2005).
15. Roybon L, Hjalt T, Christophersen NS, Li JY, Brundin P: Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3. J. Neurosci. 28, 3644-3656 (2008).
16. Spitere K, Toulouse A, O'Sullivan DB, Sullivan AM: TAT-PAX6 protein transduction in neural progenitor cells: a novel approach for generation of dopaminergic neurones in vitro. Brain Res. 1208, 25-34 (2008).
17. Kim HJ, Sugimori M, Nakafuku M, Svendsen CN: Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp. Neurol. 203, 394-405 (2007).
18. Andersson EK, Irvin DK, Ahlsio J, Parmar M: Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp. Cell Res. 313, 1172-1180 (2007).
19. O'Keeffe GW, Sullivan AM: Donor age affects differentiation of rat ventral mesencephalic stem cells. Neurosci. Lett. 375, 101-106 (2005).
20. Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL: Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors. Eur. J. Neurosci. 18, 2166-2174 (2003).
21. Svendsen CN, Clarke DJ, Rosser AE, Dunnett SB: Survival and differentiation of rat and human EGF responsive precursor cells following grafting into the lesioned adult CNS. Exp. Neurol. 137, 376-388 (1996).
22. Svendsen CN, Caldwell MA, Shen J et al.: Long term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp. Neurol. 148, 135-146 (1997).
23. Liste I, Garcia-Garcia E, Martinez-Serrano A: The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J. Neurosci. 24, 10786-10795 (2004).
24. Studer L, Tabar V, McKay RDG: Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1, 290-295 (1998).
25. Parish CL, Castelo-Branco G, Rawal N et al.: Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J. Clin. Invest. 118, 149-160 (2008).
26. Sun J, Gao Q, Miller K et al.: Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease. Neurosci. Lett. 420, 23-28 (2007).
27. Wang X, Lu Y, Zhang H et al.: Distinct effcacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int. J. Dev. Neurosci. 22, 175-183 (2004).
28. Redmond DE Jr, Bjugstad KB, Teng YD, et al.: Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc. Natl Acad. Sci. USA 104, 12175-12180 (2007).
29. Yang M, Donaldson AE, Marshall CE, Shen J, Iacovitti L: Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. Cell Transplant. 13, 535-547 (2004).
30. Balasubramaniyan V, de Haas AH, Bakels R et al.: Functionally defcient neuronal differentiation of mouse embryonic neural stem cells in vitro. Neurosci. Res. 49, 261-265 (2004).
31. Smith R, Bagga V, Fricker-Gates RA: Embryonic neural progenitor cells: the effects of species, region, and culture conditions on long-term proliferation and neuronal differentiation. J. Hematother. Stem Cell Res. 12, 713-725 (2003).
32. Brundin P, Bjorklund A: Survival of expanded dopaminergic precursors is critical for clinical trials. Nat. Neurosci. 1, 537-1998).
33. Martin GR, Evans MJ: Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl Acad. Sci. USA 72, 1441-1445 (1975).
34. Rolletschek A, Chang H, Guan K et al.: Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech. Dev. 105, 93-104 (2001).
35. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD: Effcient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18, 675-679 (2000).
36. Kawasaki H, Mizuseki K, Nishikawa S et al.: Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31-40 (2000).
37. Parmar M, Li M: Early specifcation of dopaminergic phenotype during ES cell differentiation. BMC Dev. Biol. 7, 86 (2007).
38. Baier PC, Schindehutte J, Thinyane K et al.: Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. Stem Cells 22, 396-404 (2004).
39. Kim DW: Effcient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease. Yonsei Med. J. 45(Suppl.), 23-27 (2004).
40. Yoshizaki T, Inaji M, Kouike H et al.: Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci. Lett. 363, 33-37 (2004).
41. Chung S, Shin BS, Hwang M et al.: Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24, 1583-1593 (2006).
42. Nishimura F, Yoshikawa M, Kanda S et al.: Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 21, 171-180 (2003).
43. Rodriguez-Gomez JA, Lu JQ, Velasco I et al.: Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25, 918-928 (2007).
44. Sonntag KC, Simantov R, Kim KS, Isacson O: Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur. J. Neurosci. 19, 1141-1152 (2004).
45. Martinat C, Bacci JJ, Leete T et al.: Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc. Natl Acad. Sci. USA 103, 2874-2879 (2006).
46. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al.: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56 (2002).
47. Chung S, Hedlund E, Hwang M et al.: The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol. Cell Neurosci. 28, 241-252 (2005).
48. Hedlund E, Pruszak J, Lardaro T et al.: Embryonic stem cell-derived Pitx3-enhanced green fuorescent protein midbrain dopamine neurons survive enrichment by fuorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26, 1526-1536 (2008).
49. Friling S, Andersson E, Thompson LH et al.: Effcient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc. Natl Acad. Sci. USA 106, 7613-7618 (2009).
50. Andersson E, Tryggvason U, Deng Q et al.: Identifcation of intrinsic determinants of midbrain dopamine neurons. Cell 124, 393-405 (2006).
51. Chung S, Sonntag K-C, Andersson T et al.: Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 16, 1829-1838 (2002).
52. Bjorklund LM, Sanchez-Pernaute R, Chung S et al.: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA 99, 2344-2349 (2002).
53. Inden M, Kim D, Gu Y et al.: Pharmacological characteristics of rotational behavior in hemiparkinsonian rats transplanted with mouse embryonic stem cell-derived neurons. J. Pharmacol. Sci. 96, 53-64 (2004).
54. Inden M, Kim DH, Qi M et al.: Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats. Neurosci. Lett. 387, 151-156 (2005).
55. Takagi Y, Takahashi J, Saiki H et al.: Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115, 102-109 (2005).
56. Kawasaki H, Suemori H, Mizuseki K et al.: Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl Acad. Sci. USA 99, 1580-1585 (2002).
57. Ferrari D, Sanchez-Pernaute R, Lee H, Studer L, Isacson O: Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur. J. Neurosci. 24, 1885-1896 (2006).
58. Sanchez-Pernaute R, Lee H, Patterson M et al.: Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain 131, 2127-2139 (2008).
59. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
60. Schuldiner M, Eiges R, Eden A et al.: Induced neuronal differentiation of human embryonic stem cells. Brain Res. 913, 201-205 (2001).
61. Park S, Lee KS, Lee YJ et al.: Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci. Lett. 359, 99-103 (2004).
62. Yan Y, Yang D, Zarnowska ED et al.: Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23, 781-790 (2005).
63. Geeta R, Ramnath RL, Rao HS, Chandra V: One year survival and signifcant reversal of motor defcits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem. Biophys. Res. Commun. 373, 258-264 (2008).
64. Ben Hur T, Idelson M, Khaner H et al.: Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral defcit in parkinsonian rats. Stem Cells 22, 1246-1255 (2004).
65. Carpenter M, Rao MS, Freed W, Zeng X: Derivation and characterization of neuronal precursors and dopaminergic neurons from human embryonic stem cells in vitro. Methods Mol. Biol. 331, 153-167 (2006).
66. Chiba S, Lee YM, Zhou W, Freed CR: Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into parkinsonian rats. Stem Cells 26, 2810-2820 (2008).
67. Park CH, Lee SH: Effcient generation of dopamine neurons from human embryonic stem cells. Methods Mol. Biol. 407, 311-322 (2007).
68. Ko JY, Park CH, Koh HC et al.: Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J. Neurochem. 103, 1417-1429 (2007).
69. Brederlau A, Correia AS, Anisimov SV et al.: Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24, 1433-1440 (2006).
70. Zeng X, Cai J, Chen J et al.: Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22, 925-940 (2004).
71. Perrier AL, Tabar V, Barberi T et al.: Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 101, 12543-12548 (2004).
72. Buytaert-Hoefen KA, Alvarez E, Freed CR: Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22, 669-674 (2004).
73. + cell derivation from human embryonic stem cells. Mol. Hum. Reprod. 14, 619-625 (2008).
74. Iacovitti L, Donaldson AE, Marshall CE, Suon S, Yang M: A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defned human additives: studies in vitro and in vivo. Brain Res. 1127, 19-25 (2007).
75. Vazin T, Becker KG, Chen J et al.: A novel combination of factors, termed SPIE, which promotes dopaminergic neuron differentiation from human embryonic stem cells. PLoS One. 4, E6606 (2009).
76. Schulz TC, Noggle SA, Palmarini GM et al.: Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22, 1218-1238 (2004).
77. Sonntag KC, Pruszak J, Yoshizaki T et al.: Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25, 411-418 (2007).
78. Yang D, Zhang ZJ, Oldenburg M, Ayala M, Zhang SC: Human embryonic stem cell-derived dopaminergic neurons reverse functional defcit in parkinsonian rats. Stem Cells 26, 55-63 (2008).
79. Hayashi H, Morizane A, Koyanagi M et al.: Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur. J. Neurosci. 27, 261-268 (2008).
80. Shimada H, Yoshimura N, Tsuji A, Kunisada T: Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20. J. Biosci. Bioeng. 107, 447-454 (2009).
81. Hong S, Kang UJ, Isacson O et al.: Neural precursors derived from human embryonic stem cells maintain long term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. J. Neurochem. 104, 316-324 (2008).
82. Cho MS, Lee YE, Kim JY et al.: Highly effcient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 105, 3392-3397 (2008).
83. Roy NS, Cleren C, Singh SK et al.: Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12, 1259-1268 (2006).
84. Ben-Hur T, Idelson M, Khaner H et al.: Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral defcit in parkinsonian rats. Stem Cells 22, 1246-1255 (2004).
85. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663-676 (2006).
86. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fbroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007).
87. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007).
88. Maherali N, Sridharan R, Xie W et al.: Directly reprogrammed fbroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
89. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131, 861-872 (2007).
90. Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
91. Lowry WE, Richter L, Yachechko R et al.: Generation of human induced pluripotent stem cells from dermal fbroblasts. Proc. Natl Acad. Sci. USA 105, 2883-2888 (2008).
92. Park IH, Zhao R, West JA et al.: Reprogramming of human somatic cells to pluripotency with defned factors. Nature 451, 141-146 (2008).
93. Aasen T, Raya A, Barrero MJ et al.: Effcient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284 (2008).
94. Huangfu D, Osafune K, Maehr R et al.: Induction of pluripotent stem cells from primary human fbroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275 (2008).
95. Chambers SM, Fasano CA, Papapetrou EP et al.: Highly effcient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009).
96. Wernig M, Zhao JP, Pruszak J et al.: Neuron derived from reprogrammed fbroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856-5861 (2008).
97. Cai J, Yang M, Poremsky E et al.: Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA lesioned rats. Stem Cells Dev. (2009) (Epub ahead of print).
98. Soldner F, Hockemeyer D, Beard C et al.: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 (2009).
99. Kim D, Kim C-H, Moon J-I et al.: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476 (2009).
100. Zhou H, Wu S, Joo JY et al.: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384 (2009).
101. Palmer TD, Takahashi J, Gage FH: The adult rat hippocampus contains primordial neural stem cells. Mol. Cell. Neurosci. 8, 389-404 (1997).
102. Alvarez-Buylla A, Seri B, Doetsch F: Identifcation of neural stem cells in the adult vertebrate brain. Brain Res. Bull. 57, 751-758 (2002).
103. Papanikolaou T, Lennington JB, Betz A et al.: In vitro generation of dopaminergic neurons from adult subventricular zone neural progenitor cells. Stem Cells Dev. 17, 157-172 (2008).
104. Dziewczapolski G, Lie DC, Ray J, Gage FH, Shults CW: Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. Exp. Neurol. 183, 653-664 (2003).
105. Richardson RM, Broaddus WC, Holloway KL, Fillmore HL: Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline. Brain Res. 1032, 11-22 (2005).
106. Cooper O, Isacson O: Intrastriatal transforming growth factor a delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J. Neurosci. 24, 8924-8931 (2004).
107. Zhao M, Momma S, Delfani K et al.: Evidence for neurogenesis in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA 100, 7925-7930 (2003).
108. Shan X, Chi L, Bishop M et al.: Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells 24, 1280-1287 (2006).
109. Frielingsdorf H, Schwarz K, Brundin P, Mohapel P: No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA 101, 10177-10182 (2004).
110. Lie DC, Dziewczapolski G, Willhoite AR et al.: The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22, 6639-6649 (2002).
111. Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al.: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164, 247-256 (2000).
112. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779-1782 (2000).
113. Brazelton TR, Rossi FM, Keshet GI, Blau HM: From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775-1779 (2000).
114. Ying QL, Nichols J, Evans EP, Smith AG: Changing potency by spontaneous fusion. Nature 416, 545-548 (2002).
115. Terada N, Hamazaki T, Oka M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
116. Jiang Y, Henderson D, Blackstad M et al.: Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl Acad. Sci. USA 100(Suppl. 1), 11854-11860 (2003).
117. Trzaska KA, King CC, Li KY et al.: Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J. Neurochem. 110, 1058-1069 (2009).
118. Trzaska KA, Kuzhikandathil EV, Rameshwar P: Specifcation of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25, 2797-2808 (2007).
119. Dezawa M, Kanno H, Hoshino M et al.: Specifc induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113, 1701-1710 (2004).
120. Suon S, Yang M, Iacovitti L: Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res. 1106, 46-51 (2006).
121. Thompson L, Barraud P, Andersson E, Kirik D, Bjorklund A: Identifcation of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25, 6467-6477 (2005).
122. Fukuda H, Takahashi J, Watanabe K et al.: Fluorescence-activated cell sorting-based purifcation of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24, 763-771 (2006).
123. Zhou H, Wu S, Joo JY et al.: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384 (2009).